Engineered immune cells show promise against brain metastases in preclinical study
Peer-Reviewed Publication
Updates every hour. Last Updated: 10-Jun-2026 08:16 ET (10-Jun-2026 12:16 GMT/UTC)
Researchers at Wake Forest University School of Medicine developed engineered immune cells that can cross the blood-brain barrier and slow lung cancer brain metastases, offering a promising new immunotherapy strategy.
University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.
Researchers have developed a light-activated nanoassembly that helps anticancer drugs overcome multiple intracellular barriers and reach the cell nucleus more efficiently. This strategy significantly enhances the therapeutic effect of combined phototherapy and chemotherapy in breast cancer models.
A newly published study from the University of Guam sheds light on a tiny but powerful ally in the soil and how it could help Guam farmers and growers protect their crops naturally. Published on Dec. 11, 2025, in the journal Frontiers in Plant Science, the study was conducted by Dr. Richard R. Singh, an assistant professor of sustainable plant production, and soil chemist Clancy Iyekar of the agInnovation Research Center under UOG Land Grant. The study focuses on nematodes — microscopic roundworms in soil that are poorly documented in Guam — specifically exploring how certain “good” nematodes may help control the harmful ones that damage crops.
A novel bioengineering strategy utilizing peptide display technology on the AAV1 capsid has successfully generated next-generation viral vectors with significantly enhanced specificity and efficiency for inner ear cell transduction, offering a promising advance toward targeted gene therapies for hearing and balance disorders.
Pelvic organ prolapse (POP) represents a highly prevalent condition among women, particularly following childbirth and during aging, with recurrence rates following surgical intervention posing significant clinical challenges that substantially increase treatment difficulty and healthcare burden. Despite advances in surgical techniques, the molecular mechanisms underlying POP recurrence remain poorly understood, limiting the development of targeted therapeutic strategies. A research study by Yaqian Li and colleagues employed single-cell RNA sequencing technology to conduct comprehensive comparative analysis of vaginal fibroblasts, smooth muscle cells, and macrophages between recurrent and primary POP patients, revealing substantial molecular heterogeneity that provides novel insights into the cellular and molecular drivers of POP recurrence.
Extensive bone defects pose substantial clinical challenges, frequently resulting in severe functional impairment and diminished quality of life for patients. Conventional therapeutic approaches, including autografts and allografts, remain widely utilized despite significant drawbacks such as donor site morbidity, limited availability, and potential immunogenic responses. Consequently, tissue engineering has emerged as an increasingly attractive alternative strategy. Bioceramic bone repair materials offer dual functionality by providing essential mechanical support while delivering bioactive properties that facilitate defect healing. A critical aspect of their therapeutic efficacy lies in their capacity to modulate the immune microenvironment, thereby promoting cellular behaviors and signaling pathways that favor bone regeneration. These immunoregulatory effects prove instrumental throughout the entire bone repair process and largely determine the ultimate success of regenerative outcomes. For example, hydroxyapatite demonstrates the ability to induce macrophage polarization toward the M2 phenotype, generating anti-inflammatory effects that enhance bone tissue repair. A comprehensive review published in Frontiers of Medicine systematically examines recent progress in bioceramic research for bone tissue engineering, encompassing material classification, immunomodulatory mechanisms, contemporary fabrication methodologies, and clinical translation status, with the objective of informing future investigations and improved therapeutic strategies.